Clinical Trials Logo

Clinical Trial Summary

The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05904548
Study type Interventional
Source Imricor Medical Systems
Contact Kate Lindborg, PhD
Phone 9528188400
Email kate.lindborg@imricor.com
Status Recruiting
Phase N/A
Start date June 20, 2024
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06056557 - Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy N/A
Recruiting NCT04678258 - Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation N/A
Not yet recruiting NCT06406686 - Ablation Index in Standard vs. High Power Radiofrequency Ablation for Typical Atrial Flutter: A Randomized Study (AITAF) N/A
Recruiting NCT04900831 - Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping
Completed NCT03401099 - Cryoballoon Ablation as First Line Treatment of Atrial Flutter N/A